Harrow Health (HROW) Tops Q2 EPS by 23c, Misses on Revenue
Tweet
Share
E-mailGet Alerts HROW Hot Sheet
Join SI Premium – FREE
Harrow Health (NASDAQ: HROW) reported Q2 EPS of $0.24, $0.23 better than the analyst estimate of $0.01. Revenue for the quarter came in at $63.7 million versus the consensus estimate of $66 million.
For earnings history and earnings-related data on Harrow Health (HROW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cinema United: issues joint letter to state AGs and Paramount
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- Amer Sports (AS) 89K contracts trade
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
